| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |